Physical Medicine & Rehabilitation, Pain Medicine · Orange Park, FL
NPI
1376740191
Since 2007
Specialty
Physical Medicine & Rehabilitation, Pain Medicine
Code 2081P2900X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1564 Kingsley Ave Ste 300
Orange Park, FL, 32073
Phone (904) 264-8801
Groups this clinician bills Medicare through
Medicare paid, 2024
$341K
6,088 services
Medicare patients, 2024
420
Average age 70
Drug cost, 2024
$920K
16,716 prescriptions
Company payments, 2025
$1,041
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Scott N Schimpff was code 99214 (office e&m - established), 1,586 times for 302 patients. In total Scott N Schimpff billed 6,088 services in 51 codes, and Medicare paid $341K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-08-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,586 | 302 | $87.49 | $139K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,412 | 121 | $0.09 | $122 |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 601 | 11 | $0.11 | $63.93 |
| 99213 Office E&M - Established | Office | 257 | 143 | $67.03 | $17K |
| 80307 Drug Tests | Office | 170 | 123 | $59.85 | $10K |
| G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 99 | 68 | $189.53 | $19K |
| 64483 Nerve Block Injection - Back | Office | 93 | 55 | $229.95 | $21K |
| G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 92 | 67 | $151.87 | $14K |
| 20610 Joint Injection | Office | 87 | 47 | $54.68 | $4,757 |
| 64493 Nerve Block Injection - Back | Office | 50 | 33 | $174.46 | $8,723 |
| 64494 Nerve Block Injection - Back | Office | 48 | 31 | $92.76 | $4,453 |
| 64636 Destruction by Neurolytic Agent - Back | Facility | 48 | 26 | $47.14 | $2,263 |
| J1885 Injection, ketorolac tromethamine, per 15 mg | Office | 47 | 11 | $0.58 | $27.03 |
| 64484 Nerve Block Injection - Back | Office | 45 | 32 | $93.61 | $4,213 |
| 99204 Office E&M - New | Office | 42 | 42 | $111.84 | $4,697 |
By year: 2022 $442K for 5,520 services; 2023 $407K for 5,172 services; 2024 $341K for 6,088 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80307 Drug Tests | 170 | 123 | $59.85 | $10K |
| G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 99 | 68 | $189.53 | $19K |
| G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 92 | 67 | $151.87 | $14K |
Medicare prescription drug claims, 2024
In 2024, the drug Scott N Schimpff prescribed most often to Medicare patients was Oxycodone-Acetaminophen (Oxycodone Hcl/Acetaminophen), with 3,159 prescriptions and refills. In total Scott N Schimpff wrote 16,716 Medicare prescriptions that cost $920K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 3,159 | 3,159 | 455 | $127K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 2,415 | 2,420 | 411 | $85K |
| Gabapentin Generic | 1,361 | 1,748 | 318 | $17K |
| Tizanidine Hcl Generic | 1,222 | 1,424 | 314 | $17K |
| Oxycodone Hcl Generic | 1,127 | 1,127 | 179 | $20K |
| Pregabalin Generic | 1,084 | 1,177 | 193 | $26K |
| Zolpidem Tartrate Generic | 550 | 575 | 93 | $3,450 |
| Cyclobenzaprine Hcl Generic | 540 | 672 | 135 | $8,964 |
| Morphine Sulfate Er Morphine Sulfate | 382 | 382 | 73 | $9,253 |
| Baclofen Generic | 284 | 306 | 67 | $3,894 |
| Lidocaine Generic | 257 | 319 | 80 | $38K |
| Tramadol Hcl Generic | 251 | 251 | 68 | $1,926 |
| Trazodone Hcl Generic | 243 | 310 | 65 | $1,132 |
| Ibuprofen Generic | 234 | 268 | 68 | $2,732 |
| Methocarbamol Generic | 221 | 261 | 67 | $4,638 |
Brand drugs: 1,026 claims; generic drugs: 15,690 claims; opioid claims: 8,292.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Scott N Schimpff $1,041 ($1,041 in general payments such as food, travel and fees) from 13 companies. The largest payer was Boston Scientific Corporation with $303.
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation BSX | 6 | $303 |
| Medtronic, Inc. MDT | 5 | $223 |
| Collegium Pharmaceutical, Inc. COLL | 5 | $98.08 |
| Globus Medical, Inc. GMED | 2 | $91.64 |
| Protega Pharmaceutials Inc | 2 | $79.81 |
| Abbvie Inc. ABBV | 3 | $65.74 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 3 | $49.75 |
| Abbott Laboratories ABT | 2 | $35.41 |
| SPR Therapeutics, Inc | 1 | $22.42 |
| Azurity Pharmaceuticals, Inc. | 1 | $22.28 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.